185 related articles for article (PubMed ID: 2063840)
1. Can the nephrologist prevent dialysis-related amyloidosis?
Zingraff J; Drüeke T
Am J Kidney Dis; 1991 Jul; 18(1):1-11. PubMed ID: 2063840
[TBL] [Abstract][Full Text] [Related]
2. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
Jaradat MI; Moe SM
Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
[TBL] [Abstract][Full Text] [Related]
3. [Beta 2-microglobulin and dialysis-related amyloidosis].
Gejyo F
Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
[TBL] [Abstract][Full Text] [Related]
4. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
Floege J; Koch KM
Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
[No Abstract] [Full Text] [Related]
5. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations.
Lornoy W; Becaus I; Billiouw JM; Sierens L; Van Malderen P; D'Haenens P
Nephrol Dial Transplant; 2000; 15 Suppl 1():49-54. PubMed ID: 10737167
[TBL] [Abstract][Full Text] [Related]
6. Haemodialysis-associated beta 2M amyloidosis: current controversies.
Stein G; Sperschneider H; Fünfstück R; Ritz E
Nephrol Dial Transplant; 1994; 9 Suppl 3():48-50. PubMed ID: 8072726
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and therapeutic aspects of dialysis-related amyloidosis].
Kopeć J
Przegl Lek; 2006; 63(7):567-72. PubMed ID: 17203811
[TBL] [Abstract][Full Text] [Related]
8. High-efficiency dialysis with PMMA dialyzers: treatment dose delivery and long-term results.
David S; Cambi V
Contrib Nephrol; 1999; 125():96-110. PubMed ID: 9895434
[No Abstract] [Full Text] [Related]
9. Beta-2-microglobulin removal by hemodialysis with polymethylmethacrylate membranes.
Campistol JM; Torregrosa JV; Ponz E; Fenollosa B
Contrib Nephrol; 1999; 125():76-85. PubMed ID: 9895432
[No Abstract] [Full Text] [Related]
10. Pathogenesis and management of dialysis-related amyloid bone disease.
Nangaku M; Miyata T; Kurokawa K
Am J Med Sci; 1999 Jun; 317(6):410-5. PubMed ID: 10372842
[TBL] [Abstract][Full Text] [Related]
11. Beta-2-microglobulin amyloidosis and renal bone disease.
Drüeke TB
Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
[TBL] [Abstract][Full Text] [Related]
12. beta2-microglobulin-derived amyloidosis: an update.
Floege J; Ketteler M
Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
[TBL] [Abstract][Full Text] [Related]
13. Hemodialysis-related amyloidosis: Is it still relevant?
Kaneko S; Yamagata K
Semin Dial; 2018 Nov; 31(6):612-618. PubMed ID: 29896815
[TBL] [Abstract][Full Text] [Related]
14. [Prevention of dialysis-related amyloidosis].
Yamamoto S; Gejyo F; Kazama JJ
Nihon Rinsho; 2004 Jun; 62 Suppl 6():353-6. PubMed ID: 15250323
[No Abstract] [Full Text] [Related]
15. Beta 2-microglobulin amyloidosis.
Saito A
Nephrol Dial Transplant; 1994; 9 Suppl 2():116-9. PubMed ID: 8065602
[No Abstract] [Full Text] [Related]
16. Nontransplant therapy for dialysis-related amyloidosis.
Copley JB; Lindberg JS
Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
[TBL] [Abstract][Full Text] [Related]
17. [Amyloidosis associated with dialysis].
Mátyus J; Kakuk G
Orv Hetil; 1995 Mar; 136(11):587-93. PubMed ID: 7700615
[TBL] [Abstract][Full Text] [Related]
18. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
Floege J; Schäffer J; Koch KM
Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
[TBL] [Abstract][Full Text] [Related]
19. New aspects in the pathogenesis of dialysis-related amyloidosis: pathophysiology of advanced glycation end products in renal failure.
Miyata T
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):191-7. PubMed ID: 8699608
[TBL] [Abstract][Full Text] [Related]
20. Amyloidosis and its relationship to different dialysers.
van Ypersele de Strihou C; Floege J; Jadoul M; Koch KM
Nephrol Dial Transplant; 1994; 9 Suppl 2():156-61. PubMed ID: 8065608
[No Abstract] [Full Text] [Related]
[Next] [New Search]
